Health care companies in the United States by P/B ratio
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
MiniMed Group has the lowest figure of the 128 health care companies in the United States ranked by P/B ratio, at 1.2, followed by Bio-Rad Laboratories (1.3) and CVS Health (1.3). Figures as of 21 Nov 2026, 07:04 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 128
- Lowest
- MiniMed Group1.2
- Median
- 5.3
- Combined market value
- ZAR 128.39T
- Countries
- 1
- Not ranked
- 12no P/B ratio on file
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | P/B ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | MiniMed GroupMMED · Health Care | 1.2 | ZAR 79.2B | ZAR 281.55 | 1.54% down | 12% down | ||
| 2 | Bio-Rad LaboratoriesBIO · Health Care | 1.3 | ZAR 169.7B | ZAR 6,311.54 | 2.34% down | 16% up | ||
| 3 | CVS HealthCVS · Health Care | 1.3 | ZAR 1.82T | ZAR 1,421.64 | 1.00% up | 3% up | ||
| 4 | Cooper CompaniesCOO · Health Care | 1.3 | ZAR 196.9B | ZAR 1,035.45 | 2.40% down | 20% down | ||
| 5 | Universal Health ServicesUHS · Health Care | 1.4 | ZAR 181.9B | ZAR 3,155.42 | 2.54% up | 25% down | ||
| 6 | CenteneCNC · Health Care | 1.4 | ZAR 555.3B | ZAR 1,121.62 | 2.74% down | 80% up | ||
| 7 | Zimmer Biomet HoldingsZBH · Health Care | 1.5 | ZAR 336.5B | ZAR 1,777.92 | 0.36% down | 10% up | ||
| 8 | ViatrisVTRS · Health Care | 1.6 | ZAR 395.8B | ZAR 345.21 | 1.26% down | 90% up | ||
| 9 | Cigna GroupCI · Health Care | 1.6 | ZAR 1.26T | ZAR 4,763.99 | 0.78% down | 2% down | ||
| 10 | AvantorAVTR · Health Care | 1.7 | ZAR 176.8B | ZAR 260.97 | 1.85% down | 31% up | ||
| 11 | PfizerPFE · Health Care | 1.8 | ZAR 2.75T | ZAR 481.85 | 0.51% down | 10% up | ||
| 12 | GRAILGRAL · Health Care | 1.8 | ZAR 78.5B | ZAR 1,745.39 | 5.33% down | 12% up | ||
| 13 | Globus MedicalGMED · Health Care | 1.9 | ZAR 155.8B | ZAR 1,176.31 | 2.49% down | 20% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | 1.9 | ZAR 205.8B | ZAR 1,062.36 | 1.64% down | 12% up | ||
| 15 | TeleflexTFX · Health Care | 1.9 | ZAR 112.7B | ZAR 2,841.51 | 1.11% down | 48% up | ||
| 16 | Elevance HealthELV · Health Care | 1.9 | ZAR 1.5T | ZAR 6,937.25 | 1.11% up | 21% up | ||
| 17 | Elanco Animal HealthELAN · Health Care | 1.9 | ZAR 226.3B | ZAR 452.66 | 2.09% down | 18% up | ||
| 18 | BiogenBIIB · Health Care | 1.9 | ZAR 648.8B | ZAR 4,389.24 | 1.00% up | 41% up | ||
| 19 | Baxter InternationalBAX · Health Care | 2.0 | ZAR 231B | ZAR 446.50 | 0.00% | 39% up | ||
| 20 | RevvityRVTY · Health Care | 2.2 | ZAR 285.1B | ZAR 2,553.81 | 4.20% down | 54% up | ||
| 21 | Legend BiotechLEGN · Health Care | 2.3 | ZAR 52B | ZAR 268.18 | 5.28% down | 43% down | ||
| 22 | Becton, DickinsonBDX · Health Care | 2.4 | ZAR 1.02T | ZAR 3,741.91 | 0.05% up | 40% up | ||
| 23 | Boston ScientificBSX · Health Care | 2.4 | ZAR 1.07T | ZAR 738.25 | 2.35% down | 56% down | ||
| 24 | Molina HealthcareMOH · Health Care | 2.5 | ZAR 182.1B | ZAR 3,488.85 | 2.43% down | 44% up | ||
| 25 | HumanaHUM · Health Care | 2.5 | ZAR 823.7B | ZAR 6,858.46 | 2.63% up | 67% up | ||
| 26 | Align TechnologyALGN · Health Care | 2.5 | ZAR 192.3B | ZAR 2,728.79 | 2.82% down | 12% up | ||
| 27 | Edgewise TherapeuticsEWTX · Health Care | 2.7 | ZAR 76.8B | ZAR 701.76 | 3.07% down | 82% up | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 2.8 | ZAR 1.67T | ZAR 16,191.07 | 0.19% down | 22% up | ||
| 29 | MedlineMDLN · Health Care | 2.8 | ZAR 857.2B | ZAR 651.38 | 2.11% down | 8% down | ||
| 30 | WatersWAT · Health Care | 2.8 | ZAR 1.52T | ZAR 7,745.67 | 3.51% down | 16% up | ||
| 31 | DanaherDHR · Health Care | 2.9 | ZAR 2.73T | ZAR 3,875.21 | 3.16% down | 0% up | ||
| 32 | Merit Medical SystemsMMSI · Health Care | 2.9 | ZAR 88.9B | ZAR 1,483.19 | 0.08% down | 3% down | ||
| 33 | Henry ScheinHSIC · Health Care | 2.9 | ZAR 162.4B | ZAR 1,468.77 | 1.51% down | 16% up | ||
| 34 | SolventumSOLV · Health Care | 3.0 | ZAR 252.6B | ZAR 1,486.00 | 1.52% down | 3% up | ||
| 35 | UnitedHealth GroupUNH · Health Care | 3.1 | ZAR 5.36T | ZAR 5,976.53 | 2.84% up | 3% up | ||
| 36 | GE HealthCare TechnologiesGEHC · Health Care | 3.1 | ZAR 641.2B | ZAR 1,418.12 | 1.53% down | 7% up | ||
| 37 | VaxcytePCVX · Health Care | 3.3 | ZAR 154.2B | ZAR 974.08 | 5.09% down | 22% up | ||
| 38 | Labcorp HoldingsLH · Health Care | 3.4 | ZAR 524.2B | ZAR 6,456.27 | 0.47% down | 39% up | ||
| 39 | Oscar HealthOSCR · Health Care | 3.5 | ZAR 135.1B | ZAR 434.90 | 5.50% down | 94% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 3.5 | ZAR 3.14T | ZAR 1,811.34 | 0.84% down | 19% down | ||
| 41 | LifeStance Health GroupLFST · Health Care | 3.5 | ZAR 92.4B | ZAR 243.04 | 3.60% up | 107% up | ||
| 42 | Option Care HealthOPCH · Health Care | 3.6 | ZAR 83.2B | ZAR 555.54 | 0.06% down | 7% up | ||
| 43 | Quest DiagnosticsDGX · Health Care | 3.7 | ZAR 499.7B | ZAR 4,542.06 | 0.31% down | 35% up | ||
| 44 | United TherapeuticsUTHR · Health Care | 3.7 | ZAR 415.5B | ZAR 9,755.37 | 0.78% down | 18% up | ||
| 45 | BrukerBRKR · Health Care | 3.8 | ZAR 151.6B | ZAR 992.89 | 9.08% down | 31% up | ||
| 46 | Dianthus TherapeuticsDNTH · Health Care | 3.8 | ZAR 83.7B | ZAR 1,486.88 | 0.33% down | 105% up | ||
| 47 | Tenet HealthcareTHC · Health Care | 3.8 | ZAR 368.4B | ZAR 4,628.41 | 0.15% down | 37% up | ||
| 48 | Neurocrine BiosciencesNBIX · Health Care | 3.9 | ZAR 268B | ZAR 2,647.89 | 3.84% down | 10% up | ||
| 49 | HealthEquityHQY · Health Care | 3.9 | ZAR 137.8B | ZAR 1,666.25 | 2.70% down | 4% down | ||
| 50 | Ensign GroupENSG · Health Care | 4.0 | ZAR 180.9B | ZAR 3,100.73 | 0.15% down | 5% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | 4.0 | ZAR 68.2B | ZAR 498.38 | 3.87% down | 176% up | ||
| 52 | IncyteINCY · Health Care | 4.1 | ZAR 410.9B | ZAR 2,015.77 | 1.07% down | 14% up | ||
| 53 | RepligenRGEN · Health Care | 4.4 | ZAR 184.1B | ZAR 2,880.73 | 3.81% down | 5% up | ||
| 54 | Royalty PharmaRPRX · Health Care | 4.5 | ZAR 692.1B | ZAR 1,203.75 | 1.08% up | 74% up | ||
| 55 | Thermo Fisher ScientificTMO · Health Care | 4.5 | ZAR 4.36T | ZAR 11,774.40 | 2.79% down | 17% up | ||
| 56 | MSA SafetyMSA · Health Care | 4.6 | ZAR 115.2B | ZAR 2,990.11 | 3.52% down | 13% up | ||
| 57 | Charles River Laboratories InternationalCRL · Health Care | 4.7 | ZAR 264.9B | ZAR 5,527.57 | 4.15% down | 96% up | ||
| 58 | RadNetRDNT · Health Care | 4.9 | ZAR 96.6B | ZAR 1,225.91 | 0.29% up | 16% down | ||
| 59 | Encompass HealthEHC · Health Care | 4.9 | ZAR 230.6B | ZAR 2,350.34 | 1.04% up | 16% up | ||
| 60 | Lantheus HoldingsLNTH · Health Care | 4.9 | ZAR 117.4B | ZAR 1,795.51 | 0.00% | 83% up | ||
| 61 | StrykerSYK · Health Care | 5.0 | ZAR 2.08T | ZAR 5,451.60 | 0.98% down | 15% down | ||
| 62 | Bristol-Myers SquibbBMY · Health Care | 5.1 | ZAR 2.11T | ZAR 1,034.05 | 0.79% up | 26% up | ||
| 63 | ErascaERAS · Health Care | 5.2 | ZAR 84B | ZAR 239.34 | 4.29% down | 387% up | ||
| 64 | Bio-TechneTECH · Health Care | 5.3 | ZAR 200.8B | ZAR 1,277.96 | 0.04% down | 18% up | ||
| 65 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | ZAR 338.8B | ZAR 2,529.19 | 2.71% down | 66% down | ||
| 66 | Oruka TherapeuticsORKA · Health Care | 5.4 | ZAR 114.3B | ZAR 1,684.90 | 1.80% down | 233% up | ||
| 67 | Edwards LifesciencesEW · Health Care | 5.4 | ZAR 1.03T | ZAR 1,791.11 | 1.95% down | 22% up | ||
| 68 | ResMedRMD · Health Care | 5.6 | ZAR 582.8B | ZAR 4,143.74 | 0.53% down | 6% down | ||
| 69 | PACS GroupPACS · Health Care | 5.7 | ZAR 121.9B | ZAR 767.97 | 1.49% up | 56% up | ||
| 70 | InsuletPODD · Health Care | 5.9 | ZAR 162.5B | ZAR 2,341.90 | 2.96% down | 59% down | ||
| 71 | Ligand PharmaceuticalsLGND · Health Care | 6.0 | ZAR 100.9B | ZAR 5,044.49 | 0.03% down | 44% up | ||
| 72 | BrightSpring Health ServicesBTSG · Health Care | 6.0 | ZAR 220.1B | ZAR 1,105.97 | 1.77% down | 85% up | ||
| 73 | IQVIA HoldingsIQV · Health Care | 6.1 | ZAR 712.4B | ZAR 4,322.94 | 1.89% down | 11% up | ||
| 74 | HaemoneticsHAE · Health Care | 6.1 | ZAR 96.2B | ZAR 2,113.11 | 0.17% down | 53% up | ||
| 75 | Kymera TherapeuticsKYMR · Health Care | 6.1 | ZAR 173.1B | ZAR 2,027.82 | 3.42% down | 81% up | ||
| 76 | Vertex PharmaceuticalsVRTX · Health Care | 6.2 | ZAR 2.3T | ZAR 9,057.04 | 1.08% down | 22% up | ||
| 77 | VeradermicsMANE · Health Care | 6.3 | ZAR 88.7B | ZAR 2,101.85 | 3.92% down | 230% up | ||
| 78 | Krystal BiotechKRYS · Health Care | 6.4 | ZAR 161B | ZAR 5,432.08 | 2.19% down | 49% up | ||
| 79 | Agilent TechnologiesA · Health Care | 6.5 | ZAR 844.8B | ZAR 2,996.27 | 2.83% down | 16% up | ||
| 80 | Praxis Precision MedicinesPRAX · Health Care | 6.7 | ZAR 147.7B | ZAR 5,283.30 | 3.37% down | 83% up | ||
| 81 | Belite BioBLTE · Health Care | 6.7 | ZAR 91B | ZAR 2,240.08 | 15.65% down | 25% up | ||
| 82 | CG OncologyCGON · Health Care | 7.2 | ZAR 124.8B | ZAR 1,397.54 | 2.97% down | 93% up | ||
| 83 | Protagonist TherapeuticsPTGX · Health Care | 7.3 | ZAR 139.3B | ZAR 2,134.92 | 2.11% down | 45% up | ||
| 84 | Merck & CoMRK · Health Care | 7.3 | ZAR 5.8T | ZAR 2,351.57 | 0.69% up | 36% up | ||
| 85 | BillionToOneBLLN · Health Care | 7.6 | ZAR 75.5B | ZAR 1,581.32 | 0.31% down | 18% down | ||
| 86 | Caris Life SciencesCAI · Health Care | 7.9 | ZAR 88.7B | ZAR 309.16 | 5.18% down | 23% down | ||
| 87 | Twist BioscienceTWST · Health Care | 7.9 | ZAR 123.9B | ZAR 1,816.96 | 7.44% down | 291% up | ||
| 88 | PenumbraPEN · Health Care | 7.9 | ZAR 221.2B | ZAR 5,611.98 | 0.28% down | 11% up | ||
| 89 | Johnson & JohnsonJNJ · Health Care | 8.0 | ZAR 11.45T | ZAR 4,756.43 | 1.25% up | 31% up | ||
| 90 | 10x GenomicsTXG · Health Care | 8.1 | ZAR 119.8B | ZAR 910.94 | 9.72% down | 213% up | ||
| 91 | ChemedCHE · Health Care | 8.3 | ZAR 125B | ZAR 9,647.39 | 0.50% down | 25% up | ||
| 92 | Corcept TherapeuticsCORT · Health Care | 8.3 | ZAR 122.4B | ZAR 1,118.81 | 2.09% down | 16% down | ||
| 93 | ExelixisEXEL · Health Care | 8.6 | ZAR 277.3B | ZAR 1,136.57 | 1.82% down | 55% up | ||
| 94 | Intuitive SurgicalISRG · Health Care | 8.7 | ZAR 2.43T | ZAR 7,017.61 | 2.01% down | 27% down | ||
| 95 | West Pharmaceutical ServicesWST · Health Care | 9.2 | ZAR 478.1B | ZAR 6,863.74 | 1.61% down | 46% up | ||
| 96 | Spyre TherapeuticsSYRE · Health Care | 9.3 | ZAR 156.1B | ZAR 1,643.74 | 4.26% down | 302% up | ||
| 97 | IlluminaILMN · Health Care | 9.3 | ZAR 512.7B | ZAR 3,390.89 | 3.90% down | 62% up | ||
| 98 | Hims & Hers HealthHIMS · Health Care | 9.6 | ZAR 60.2B | ZAR 256.75 | 8.86% down | 54% down | ||
| 99 | ZoetisZTS · Health Care | 9.8 | ZAR 565.3B | ZAR 1,391.21 | 2.08% down | 34% down | ||
| 100 | ImmunovantIMVT · Health Care | 10.0 | ZAR 115.6B | ZAR 558.70 | 2.31% down | 44% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5858 ZAR). 12 companies have no P/B ratio on file and are not ranked here.
Questions and answers
Which health care companies in the United States have the lowest P/B ratio?
MiniMed Group (1.2), Bio-Rad Laboratories (1.3) and CVS Health (1.3) have the lowest P/B ratio of the 128 health care companies in the United States ranked here as of 21 Nov 2026, 07:04 UTC.
How many health care companies in the United States are in this ranking?
128 are ranked by P/B ratio. 12 more have no P/B ratio on file and are left out rather than ranked at zero.
What are these health care companies in the United States worth together?
The 128 health care companies in the United States ranked by P/B ratio have a combined market value of ZAR 128.39T as of 21 Nov 2026, 07:04 UTC.
What does ranking by P/B ratio measure?
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies in the United States by P/B ratio”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=pb-ratio
Underlying data: Yahoo Finance; SEC EDGAR.